Mate Tea (Ilex paraguariensis) Improves Glycemic and Lipid Profiles of Type 2 Diabetes and Pre-Diabetes Individuals: A Pilot Study

Journal of the American College of Nutrition

Volumn 30, Issue 5, 2011, Pages 320-332

  Klein, Graziela A ^a   Stefanuto, Aliny ^a   Boaventura, Brunna C B ^a   De Morais, Elayne C ^a   Da Cavalcante, Luciana S ^a   De Andrade, Fernanda ^a   Wazlawik, Elisabeth ^a   Di Pietro, Patrícia F ^a   Maraschin, Marcelo ^a   Da Silva, Edson L ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Diabetes mellitus; Dietary counseling; Glycemic control; Ilex paraguariensis; Lipid profile; Mate tea

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID; ADVANCED GLYCATION END PRODUCT; ANTIDIABETIC AGENT; LIPID; PLANT EXTRACT; TRIACYLGLYCEROL;

ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY FIBER; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILEX PARAGUARIENSIS; IMPAIRED GLUCOSE TOLERANCE; LOW FAT DIET; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; PILOT STUDY; TEA; YERBA MATE TEA; AGED; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FAT INTAKE; FEMALE; GLYCEMIC INDEX; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ANIMALIA; CROTON OVALIFOLIUS; ILEX PARAGUARIENSIS;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FEMALE; GLYCEMIC INDEX; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPOGLYCEMIC AGENTS; ILEX PARAGUARIENSIS; LIPIDS; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT EXTRACTS; PREDIABETIC STATE; SINGLE-BLIND METHOD; TRIGLYCERIDES;

EID: 84857699355     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2011.10719975     Document Type: Article

References (41)

1. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14, 2010.
2. American Diabetes Association: Standards of medical care in diabetes-2010. Diabetes Care 33:S11-S61, 2010.
3. National Cholesterol Education Program (NCEP): Third report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final reports. Circulation 106:3143-3421, 2002.
4. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (UKPDS Group): Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000.
5. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413-420, 2004.
6. Xanthis A, Hatzitolios A, Koliakos G, Tatola V: Advanced glycosylation end products and nutrition-a possible relation with diabetic atherosclerosis and how to prevent it. J Food Sci 72:125-129, 2007.
7. Bantle JP, Wylie-Rosette J, Albright AL, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AG, Wheeler ML: Nutrition recommendations and intervention for Diabetes 2006: a position statement of the American Diabetes Association. Diabetes Care 31:S61-S78, 2008.
8. Rivellese AA, Boemi M, Cavalot F, Costagliola L, De Feo P, Miccoli R, Patti L, Trovati M, Vaccaro O, Zavaroni I: Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? Eur J Clin Nutr 62:660-664, 2008.
9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002.
10. Nahas R, Moher M: Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 55:591-596, 2009.
11. Bastos DHM, Oliveira DM, Matsumoto RLT, Carvalho PO, Ribeiro ML: Yerba maté: pharmacological, properties, research and biotechnology. Med Arom Plant Sci Biotechnol 1:37-46, 2007.
12. Heck CI, De Mejia EG: Yerba mate tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations. J Food Sci 72:R138-R151, 2007.
13. Morais EC, Stefanuto A, Klein GA, Boaventura BCB, Andrade F, Wazlawik E, Di Pietro PF, Maraschin M, Silva EL: Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy. J Agric Food Chem 57:8316-8324, 2009.
14. Gugliucci A: Antioxidant effects of Ilex paraguariensis: induction of decreased oxidizability of human LDL in vivo. Biochem Biophys Res Commun 224:338-344, 1996.
15. Silva EL, Neiva TJC, Shirai M, Terao J, Abdalla DSP: Acute ingestion of yerba mate infusion (Ilex paraguariensis) inhibits plasma and lipoprotein oxidation. Food Res Int 41:973-979, 2008.
16. Matsumoto RT, Mendonca S, Nunes VS, Bartchewsky W Jr, Ribeiro M, Carvalho PO, Bastos DHM: Effects of mate tea (Ilex paraguariensis) ingestion on mRNA expression of antioxidant enzymes, lipid peroxidation, and total antioxidant status in healthy young women. J Agric Food Chem 57:1775-1780, 2009.
17. Andersen T, Fogh J: Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. Br Diet Assoc 14:243-250, 2001.
18. Sotillo RDV, Hadley M: Chlorogenic acid modifies plasma and liver concentrations of cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 13:717-726, 2002.
19. Pang J, Cho Y, Park T: Ilex paraguariensis extract ameliorates obesity induced by high-fat diet: potential role of AMPK in the visceral adipose tissue. Arch Biochem Biophys 476:178-185, 2008.
20. Oliveira DM, Freitas HS, Souza MF, Ribeiro ML, Carvalho PO, Bastos DH: Yerba mate (Ilex paraguariensis) aqueous extract decreases intestinal SGLT1 gene expression but does not affect other biochemical parameters in alloxan-diabetic Wistar rats. J Agric Food Chem 56:10527-10532, 2008.
21. Luncerford N, Gugliucci A: Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea. Fitoterapia 76:419-427, 2005.
22. Sociedade Brasileira de Diabetes: ''Princípios para Orientacao Nutricional no Diabetes Mellitus.'' Rio de Janeiro: Diretrizes da Sociedade Brasileira de Diabetes, pp 22-25, 2007.
23. American Diabetes Association: Nutrition recommendations and interventions for diabetes. Diabetes Care 31:S61-S78, 2008.
24. Kalousová M, Zima T, Tesar V, Skrha J, Stipek S: Determination of advanced glycation end-products and advanced oxidation protein products. Klin Biochem Metab 10:11-16, 2002.
25. Sokal RR, Rohlf FJ: ''Biometry: The Principles and Practice of Statistics in Biological Research,'' 3rd ed. New York: WH Freeman, 1995.
26. Natale CD, Annuzzi G, Bozzeto L, Mazzarela R, Costabile G, Ciano O, Riccardi G, Rivellese AA: Effects of a plant-based highcarbohydrate/ high-fiber diet versus high-monounsaturated fat/lowcarbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care 32:2168-2173, 2009.
27. Summers LK, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, Moore NR, Frayn KN: Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45:369-377, 2002.
28. Martinet A, Hostettmann K, Schutz Y. Thermogenic effects of commercially available plant preparations aimed at treating human obesity. Phytomedicine 6:231-238, 1999.
29. Hemmerle H, Burger HJ, Below P, Schubert G, Rippel R, Schindler PW, Paulus E, Herling AW: Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-translocase. J Med Chem 40:137-145, 1997.
30. Prasad CN, Anjana T, Banerji A, Gopalakrishnapillai A: Gallic acid induces GLUT4 translocation and glucose uptake activity in 3T3-L1 cells. FEBS Lett 584:531-536, 2010.
31. Huang D, Shen S, Wu JS: Effects of caffeic acid and cinnamic acid on glucose uptake in insulin-resistant mouse hepatocytes. J Agric Food Chem 57:7687-7692, 2009.
32. Keijzers GB, De Galan BE, Tack CJ, Smits P: Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25:364-369, 2002.
33. Yamauchi R, Kobayashi M, Matsuda Y, Ojika M, Shigeoka S, Yamamoto Y, Tou Y, Inoue T, Katagiri T, Murai A, Horio F: Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. J Agric Food Chem 58:5597-5603, 2010.
34. Diabetes Nutrition and Complications Trial: Adherence to the ADA nutritional recommendations, targets of metabolic control, and onset of diabetes complication: a 7-year, prospective, population-based, observational multicenter study. J Diabetes Complicat 20:361-366, 2006.
35. Norris SL, Zhang X, Avenell A, Gregg E, Bowman B, Schmid CH, Lau J: Longterm effectiveness of weight-loss interventions in adults with pre-diabetes: a review. Am J Prev Med 28:126-139, 2005.
36. Ferreira F, Vázquez A, Güntner C, Moyna P: Inhibition of the passive diffusion of cholic acid by the Ilex paraguariensis A. St. Hil. saponins. Phytother Res 11:79-81, 1997.
37. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo Y, Yayabe Y, Sugano M: Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1127:141-146, 1992.
38. Wang S, Noh SK, Koo SI: Epigallocatechin-gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats. J Nutr 136:2791-2796, 2006.
39. Gebhardt R: Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts. J Pharmacol Exp Ther 286:1122-1128, 1998.
40. Yeh YH, Lee YT, Hsieh HS, Hwang DF: Dietary caffeic acid, ferulic acid and coumaric acid supplements on cholesterol metabolism and antioxidant activity in rats. J Food Drug Anal 17:123-132, 2009.
41. McLaughlin T, Schweitzer P, Carter S, Yen CG, Lamendola C, Abbasi F, Reaven G: Persistence of improvement in insulin sensitivity following a dietary weight loss program. Diabetes Obes Metab 10:1186-1194, 2008.